Britain's blue-chip FTSE 100 kicked off the week higher on Monday, boosted by heavyweight healthcare and defence stocks, on ...

Looking for the latest stock opportunities in March 2025? We have you covered. Click to read our top stock picks to consider ...

For the six months ended 31 December, the ASX 200 healthcare stock reported a 28.1% increase in sales to a record of $54.1 ...

UnitedHealth Group faces unconfirmed allegations of inflating risk ratings for reimbursements, causing market panic despite ...

The medical sector took a beating in 2024, leaving many battered and trading near 52-week lows heading into 2025. While the ...

Hartford Capital Appreciation Fund (I share) underperformed the Russell 3000 Index during the quarter. Read more here.

Asian equities were largely lower despite a weaker US dollar overnight, as Japan outperformed and India underperformed.

On Friday, the Food and Drug Administration declared the semaglutide shortage over, sending Hims & Hers shares down 26%.

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Globus Medical (GMED – Research Report) and Nevro Corp (NVRO ...

Citi Group has upgraded Indian stocks with an overweight rating from neutral stating that the strategists see meaningful ...

Leerink Partners Global Healthcare Conference, Miami Wednesday, March 12, 2025 (1x1 meetings) The live and archived webcasts will be accessible from the Company’s website at https://brightmindsbio.com ...

Healthcare has lagged the S&P 500 over the past two years, with investors showing real interest in mega-cap tech and growth stocks based on the artificial intelligence (AI) boom. While a late-year ...